- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05042778
Is Auriculotherapy Responsible for Improvements on Anxiety Students' Prior and After Examinations?
Is Auriculotherapy Responsable for Improvements on Anxiety Students' Prior and After Examinations?
Study Overview
Detailed Description
To treat anxiety, conventional medicine relies on medicines such as benzodiazepines, antidepressants, barbiturates, and antihistamines. However, several authors have reported western medicine cannot resolve all anxiety diseases and the risk of side effects, resistance to pharmacological treatments affects approximately one in three patients with anxiety disorders.
Alternatively, auriculotherapy is a technique similar to reflexology. It is speculated the technique might work in anxiety because groups of pluripotent cells contain information from the whole organism creating regional organization centres representing different parts of the body, through the recruitment of more cortex cells dedicated to specific body areas. Thus reflex points in the ear can incite body responses by the stimulation of reticular formation and the sympathetic and parasympathetic nervous systems. The information that comes from the thermal, Algic and proprioceptive stimuli are transmitted from the auricular pavilion by the fibres of the nerves: trigeminal; Auricular magnum and minor occipital (sensitive branch of the cervical plexus) and the vagus nerve. The vagus nerve is responsible for the parasympathetic innervation of the lung, heart, stomach, and small intestine, as well as the pharynx and larynx muscles and it also sends information to important brain regions (e.g., locus coeruleus, orbitofrontal cortex, hippocampus and at amygdala) in the regulation of anxiety. In turn, the trigeminal nerve controls, mainly, the mastication muscles and the facial sensitivity while the cervical plexus nerve is responsible for neck muscles, diaphragm, and thorax.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Porto, Portugal, 4050-313 Porto
- ICBAS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- University students
- Unfamiliar with auriculotherapy,
- No psychological disorders measured through Brief Symptom Inventory scale.
Exclusion Criteria:
- Students having any neurological disease, cardiovascular disease, renal disease or any chronic disease, such as diabetes or hypertension.
- Pregnants.
- Under psychiatric medication.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Auriculotherapy
Indwelling fixed semipermanent needles embedded in a skin-colored adhesive tape will be used in active points around the vagus nerve stimulation area.
|
A licensed acupuncturist (holder of civil liability insurance) with more than nine years of experience with this technique will apply auriculotherapy.
Indwelling fixed semipermanent needles embedded in a skin-coloured adhesive tape will be used at the actives auricular points around the vagus nerve area.
|
|
No Intervention: No intervention
No auriculotherapy will be applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Spielberger's State-Trait-Anxiety Inventory (STAI)
Time Frame: Change from baseline to after 8 and 24 hours.
|
Was developed by Spielberger and colleagues in 1970, validated for the Portuguese population, with the aim of analyzing anxiety symptoms.
STAI is an instrument for measuring the state and trait of anxiety, consisting of two auto-answer questionnaires, each consisting of 20 items.
The score ranges from 20 to 80 points on both scales, where 20 to 35 points means not anxious, 36 to 50 points is considered little anxious; 51 to 65 points means moderately anxious; and finally, 66 to 80 points the participant is considered very anxious.
|
Change from baseline to after 8 and 24 hours.
|
|
Change on Salivary amylase (U/ml)
Time Frame: Change from baseline to after 16 hours.
|
The method responds to both pancreatic and salivary amylase isoenzymes.
Samples will be diluted prior to analysis and all measurements are going to be in compliance with the national legal requirements.
|
Change from baseline to after 16 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Visual analogic scale (VAS) for anxiety
Time Frame: Change from one week before baseline to after 8 and 24 hours.
|
Consists of a horizontal or vertical line, 100 mm long, which has marked the classification "totally calm and relaxed" at one end and, at the other, the classification "Worst fear imaginable".
The respondent should mark the point that represents the degree of intensity of his anxiety.
The distance between the beginning of the line, which corresponds to zero and the marked location, is then measured in centimeters, thus obtaining a numerical classification.
The scale is reliable and correlated with STAI-Y1 (p <0.0001) for the level of anxiety and was used on our previous study
|
Change from one week before baseline to after 8 and 24 hours.
|
|
Change on quality of sleep
Time Frame: Change from one week before baseline to after 8 and 24 hours.
|
The participants will be asked about the quality of sleep during the night before as: 1-no change, 2-better or 3- worse than the quality of sleep during the previous week.
|
Change from one week before baseline to after 8 and 24 hours.
|
|
Change on Blood Glucose levels
Time Frame: Change from baseline to after 30 minutes and 24 hours.
|
Cortisol acts on two distinct fronts that results in increased amounts of glucose in the bloodstream.
It stimulates gluconeogenesis in the liver, and the glucose produced is released into the bloodstream and stored as glycogen.
In addition, by potentiating the effects of epinephrine, it elevates glycogenolysis in the liver, thus releasing a large amount of glucose into the bloodstream within minutes.
|
Change from baseline to after 30 minutes and 24 hours.
|
|
Test performance
Time Frame: one week after examinations
|
After the exam, the test performance (pass or fail) will also be recorded.
|
one week after examinations
|
|
Adverse effects
Time Frame: up to one week after baseline
|
We will collect data related to auriculotherapy´ adverse effects (e.g, pain, presence of hematoma, vagal reaction, and infection), by replying the Adverse effect questionnaire after the procedure, as well as 1 week after completion of the experimental session.
|
up to one week after baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jorge Machado, Ph.D, Instituto de Ciências Biomédicas Abel Salazar
Publications and helpful links
General Publications
- Vieira, A., Hinzmann, M., Silva, K., Santos, M., & Machado, J. (2018). Clinical effect of auricular acupuncture in anxiety levels of students prior to the exams: A randomized controlled trial. European Journal of Integrative Medicine, 20, 188-192. doi:https://doi.org/10.1016/j.eujim.2018.05.012
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ESSSMUporto
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on Auriculotherapy
-
Hopital FochRecruiting
-
Hopital FochCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
Hopital FochCompleted
-
Centre Francois BaclesseCompletedBreast Cancer | Musculoskeletal PainFrance
-
Jacques E. ChellyRecruiting
-
Universidade Federal do CearaCompletedChikungunya FeverBrazil
-
Marcelo Neubauer de PaulaHospital das Clínicas, University of Sao Paulo Medical SchoolNot yet recruiting